Bildyos Injection, Solution
Product Images NDC 78206-193
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Bildyos (NDC 78206-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Pic2 Henlius Step For Ifu)
Figure 3 (Pic3 Henlius Step For Ifu)
Figure 4 (Pic4 Henlius Step For Ifu)
Figure 5 (Pic5 Henlius Step For Ifu)
Figure 6 (Pic6 Henlius Fig1 Cumulative Incidence Of Hip Fractures Over 3 Years)
This text provides information on the patient hip fracture incidence (%) in a study comparing a placebo group (N=3506) to a group receiving Denosumab (N=3902) over the course of several study months. The incidence of hip fractures is indicated as 10% for the placebo group and is not available for the Denosumab group from the provided text.*
Figure 7 (Pic7 Henlius Organon Logo)
Figure 8 (Pic8 Henlius Organon Logo)
Bildyos-60mg-pfs-blister-label (Bildyos 60mg Pfs Blister Label (2))
This is a prescription medicine identified as Lot XXXXXXXXXX expiring on YYYY/MM/DD. The prefilled syringe contains 60 mg of denosumab-nxxp, along with other components. It is important to store the syringe refrigerated at 2°C to 8°C and avoid freezing, excess shaking, direct light, and heat. The syringe is for subcutaneous use only, and any unused portion should be discarded. Manufacturing is done by Shanghai Henlius Biotech, Inc., and it is a sterile solution with no preservatives.*
Bildyos-60mg-pfs-carton (Bildyos 60mg Pfs Carton (2))
This is a prescription card for BILDYOS® (denosumab-nxxp), an injectable medication used for subcutaneous administration once every 6 months. The card contains information about the dosage, administration instructions, and a reminder for the next treatment. It is important to follow the enclosed medication guide and use the prefilled syringe provided for each patient. This card is a helpful tool for tracking and managing treatments with BILDYOS®.*
Bildyos-60mg-pfs-container-label (Bildyos 60mg Pfs Container Label (2))
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.